ESAB, Elektriska Svetsnings-Aktiebolaget (English: Electric Welding Limited company), is an American-Swedish industrial company. The ultimate parent company of ESAB is ESAB Corporation, a New York Stock Exchange listed (Ticker: ESAB) with its principal executive office in North Bethesda, Maryland, U.S.3 It was founded by Oscar Kjellberg.1Wikipedia text CC BY-SA 4.0
Revenue1011129$2.8B in 2025+46% since 2020Gross profit1011129$1.0B in 2025+54% since 2020Operating income1011129$412.2M in 2025+104% since 2020Net income10129$226.8M in 2025+44% since 2020
Revenue1314$807.6M in Q2 FY2026+8% since Q1 FY2026Gross profit1314$307.2M in Q2 FY2026+12% since Q1 FY2026Operating income1314$78.7M in Q2 FY2026−13% since Q1 FY2026Net income1314$32.4M in Q2 FY2026−32% since Q1 FY2026
Every line of the income statement as filed: the last 3 fiscal years, latest first.9
Period ending
2025-12-31
2024-12-31
2023-12-31
Net sales
$2.8B
$2.7B
$2.8B
Cost of sales
$1.8B
$1.7B
$1.8B
Gross profit
$1.0B
$1.0B
$1.0B
Selling, general and administrative expense
$608.4M
$579.8M
$587.5M
Restructuring and other related charges
$27.8M
$10.2M
$24.1M
Operating income
$412.2M
$447.4M
$404.2M
Pension settlement loss
$0
$12.2M
$0
Interest expense and other, net
$83.9M
$64.9M
$85.1M
Income from continuing operations before income taxes
$328.3M
$370.4M
$319.1M
Income tax expense
$69.2M
$77.3M
$95.7M
Net income from continuing operations
$259.1M
$293.1M
$223.4M
Loss from discontinued operations, net of taxes
-$25.9M
-$22.3M
-$12.3M
Net income
$233.2M
$270.7M
$211.0M
Income attributable to noncontrolling interest, net of taxes
-$6.5M
-$5.9M
-$5.7M
Net income attributable to ESAB Corporation
$205.3M
Net income attributable to ESAB Corporation
$226.8M
$264.8M
Income from continuing operations (in dollars per share)
$4
$5
$4
Loss on discontinued operations (in dollars per share)
-$0
-$0
-$0
Net income per share (in dollars per share)
$3.71
$4.36
$3.39
Income from continuing operations (in dollars per share)
$4
$5
$4
Loss on discontinued operations (in dollars per share)
-$0
-$0
-$0
Net income per share - diluted (in dollars per share)
$3.67
$4.31
$3.36
No quarter-by-quarter statement was filed.
Total assets1011129$4.8B in 2025+38% since 2021Total liabilities1011129$2.6B in 2025+166% since 2021Shareholders’ equity1011129$2.2B in 2025−19% since 2019Cash1011129$185.9M in 2025+77% since 2019Long-term debt1011129$1.2B in 2025
Total assets1314$6.6B in Q2 FY2026+38% since Q1 FY2025Total liabilities1314$4.0B in Q2 FY2026+56% since Q1 FY2025Shareholders’ equity1314$2.5B in Q2 FY2026+17% since Q1 FY2025Cash1314$217.5M in Q2 FY2026+17% since Q1 FY2025Long-term debt1314$2.4B in Q2 FY2026+94% since Q1 FY2025
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.9
Period ending
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Cash and cash equivalents
$185.9M
$249.4M
Trade receivables, less allowance for credit losses of $21,765 and $23,850
$451.3M
$370.3M
Inventories, net
$481.8M
$403.7M
Prepaid expenses
$66.1M
$55.7M
Other current assets
$76.9M
$69.3M
Total current assets
$1.3B
$1.1B
Property, plant and equipment, net
$381.9M
$298.3M
Goodwill
$1.9B
$1.7B
$1.6B
Intangible assets, net
$673.0M
$488.0M
Lease asset - right of use
$113.3M
$89.9M
Other assets
$386.3M
$357.4M
Total assets
$4.8B
$4.0B
Current portion of long-term debt
$2.4M
$15.0M
Accounts payable
$360.4M
$318.5M
Accrued liabilities
$302.0M
$298.6M
Total current liabilities
$664.8M
$632.1M
Long-term debt
$1.2B
$1.1B
Other liabilities
$657.2M
$532.9M
Total liabilities
$2.6B
$2.2B
Common stock - $0.001 par value - 600,000,000 shares authorized; 60,721,079 and 60,517,574 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively
$61.0K
$61.0K
Additional paid-in capital
$1.9B
$1.9B
Retained earnings
$800.8M
$597.2M
Accumulated other comprehensive loss
-$539.7M
-$729.6M
Total ESAB Corporation equity
$2.2B
$1.8B
Noncontrolling interest
$45.5M
$39.2M
Total equity
$2.2B
$1.8B
$1.6B
$1.4B
Total liabilities and equity
$4.8B
$4.0B
Allowance for credit losses
$21.8M
$23.9M
Common stock, par value (in dollars per share)
$0.00
$0.00
Common stock, authorized (in shares)
600.0M shares
600.0M shares
Common stock, shares issued (in shares)
60.7M shares
60.5M shares
Common stock, shares outstanding (in shares)
60.7M shares
60.5M shares
Period ending
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Cash and cash equivalents
$185.9M
$249.4M
Trade receivables, less allowance for credit losses of $21,765 and $23,850
$451.3M
$370.3M
Inventories, net
$481.8M
$403.7M
Prepaid expenses
$66.1M
$55.7M
Other current assets
$76.9M
$69.3M
Total current assets
$1.3B
$1.1B
Property, plant and equipment, net
$381.9M
$298.3M
Goodwill
$1.9B
$1.7B
$1.6B
Intangible assets, net
$673.0M
$488.0M
Lease asset - right of use
$113.3M
$89.9M
Other assets
$386.3M
$357.4M
Total assets
$4.8B
$4.0B
Current portion of long-term debt
$2.4M
$15.0M
Accounts payable
$360.4M
$318.5M
Accrued liabilities
$302.0M
$298.6M
Total current liabilities
$664.8M
$632.1M
Long-term debt
$1.2B
$1.1B
Other liabilities
$657.2M
$532.9M
Total liabilities
$2.6B
$2.2B
Common stock - $0.001 par value - 600,000,000 shares authorized; 60,721,079 and 60,517,574 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively
$61.0K
$61.0K
Additional paid-in capital
$1.9B
$1.9B
Retained earnings
$800.8M
$597.2M
Accumulated other comprehensive loss
-$539.7M
-$729.6M
Total ESAB Corporation equity
$2.2B
$1.8B
Noncontrolling interest
$45.5M
$39.2M
Total equity
$2.2B
$1.8B
$1.6B
$1.4B
Total liabilities and equity
$4.8B
$4.0B
Allowance for credit losses
$21.8M
$23.9M
Common stock, par value (in dollars per share)
$0.00
$0.00
Common stock, authorized (in shares)
600.0M shares
600.0M shares
Common stock, shares issued (in shares)
60.7M shares
60.5M shares
Common stock, shares outstanding (in shares)
60.7M shares
60.5M shares
Cash from operations1011129$260.6M in 2025−16% since 2020Capital spending1011129$47.3M in 2025+18% since 2020Free cash flow1011129$213.3M in 2025−21% since 2020Dividends paid1011129$21.9M in 2025
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.9
Period ending
2025-12-31
2024-12-31
2023-12-31
Net income
$233.2M
$270.7M
$211.0M
Depreciation, amortization and other impairment charges
$84.1M
$66.8M
$75.0M
Net gain on sale of property, plant and equipment
-$5.6M
-$986.0K
-$1.6M
Stock-based compensation expense
$16.9M
$19.8M
$16.1M
Deferred income tax benefit
-$35.7M
-$2.6M
-$25.4M
Non-cash interest expense
$2.9M
$2.9M
$1.2M
Pension settlement loss
$0
$12.2M
$0
Trade receivables, net
-$40.0M
-$4.8M
-$6.0M
Inventories, net
-$5.6M
-$22.5M
$18.0M
Accounts payable
$6.7M
$31.9M
-$19.8M
Other operating assets and liabilities
$3.6M
-$17.9M
$62.0M
Net cash provided by operating activities
$260.6M
$355.4M
$330.5M
Purchases of property, plant and equipment
-$47.3M
-$51.8M
-$48.2M
Proceeds from sale of property, plant and equipment
$6.5M
$3.8M
$4.6M
Acquisitions, net of cash received
-$438.3M
-$153.7M
-$18.7M
Payment for (Proceeds from) Other Investing Activity
-$816.0K
-$4.1M
$0
Net cash used in investing activities
-$479.9M
-$205.7M
-$62.2M
Proceeds from borrowings on Senior Notes
$0
$700.0M
$0
Repayments of borrowings on Term Loan
-$385.0M
-$602.5M
-$12.5M
Proceeds from borrowings on Term Loan
$350.0M
$0
$0
Proceeds from borrowings on revolving credit facilities and other
$410.7M
$205.0M
$574.1M
Repayments of borrowings on revolving credit facilities and other
-$217.1M
-$237.0M
-$763.2M
Payment of debt issuance costs
-$5.4M
-$10.4M
$0
Payment of dividends
-$21.9M
-$17.0M
-$13.3M
Distributions to noncontrolling interest holders
-$4.2M
-$3.7M
-$3.9M
Other financing
-$13.4M
-$2.7M
-$972.0K
Net cash provided by (used in) financing activities
$113.7M
$31.7M
-$219.7M
Effect of foreign exchange rates on Cash and cash equivalents
ESAB is part of a group headed by Colfax Corporation. 233 entities, 52 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
DJO Medical Device Trading (Shanghai) Ltd. Subsidiary · China
DJO Nordic Aktiebolag Subsidiary · Sweden
and 73 more
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What ESAB reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Our corporate headquarters are located in North Bethesda, Maryland in a leased facility. As of December 31, 2025, we had a total of 4 production facilities in the United States and 33 production facilities outside the United States in 16 countries in Europe, Mexico, South America, the Middle East, India and Southeast Asia.
The company was founded in 1904 by Swedish businessman Oscar Kjellberg in Gothenburg, Sweden. The company sells equipment for welding and cutting.
Other notable CEO was Lars Westerberg who ran ESAB for three years.
The ESAB was acquired by Charter International in 1994.
The ESAB group was acquired by Colfax Corporation on 13 January 2012.
Following the purchase, the CEO of Colfax, Clay Kiefaber, stepped down to the president role of ESAB and was replaced by Steve Simms.
The ESAB group acquired the Welding Wire business of Sandvik effective February 1, 2018. The acquisition included production units in Scranton, PA, and Sandviken, Sweden; the technical sales and product management organization; as well as multiyear strategic collaboration on R&D for future product developments.
On April 5, 2022, Colfax Corp. (now Enovis Corp.) distributed 100% of the shares of ESAB Corporation to Colfax shareholders. The spin-off transaction was registered with the U.S. Securities and Exchange Commission through a Form 10-12B registration statement. An Information Statement was sent to Colfax shareholders.
On October 17, 2022, ESAB Corporation announced the acquisition of Ohio Medical, a global leader in oxygen regulators and central gas systems for the healthcare industry.
Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record. The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Feb 20, 2025Reported quarterly or annual results53
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
570 filings to the SEC since October 2021: 4 annual reports, 14 quarterly reports, 44 major events, 389 insider forms, 27 large holders, 92 other. The latest 20:
47 open-market trades by officers, directors and large owners since October 2021: 3 buys and 44 sales. Grants, option exercises and gifts are left out.
BlackRockSC 13G/A, 2 filings Feb 3, 2023 to Jan 26, 202460
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
From the cover page of the 10-K filed Feb 20, 2026 (Section 12(b) of the Exchange Act).15
Risk factors and legal proceedings
The risks ESAB names in Item 1A of its 10-K filed Feb 20, 2026: 37 risks under these headings, as written.15
Risks Related to our Business
The cyclical nature and maturity of the welding and cutting industry in developed markets may adversely affect our performance.
A significant or sustained decline in the levels of new capital investment and maintenance expenditures by certain of our customers could reduce the demand for our products and services and harm our operations and financial performance.
The majority of our sales are derived from international operations. We are subject to specific risks associated with international operations.
Our operations are exposed to risks related to the Russian invasion of Ukraine and could be impacted by other wars and geopolitical turmoil.
Natural or man-made disasters, adverse weather events or conditions, epidemics, pandemics and other widespread health events have adversely impacted, and may in the future adversely impact, our results of operations, financial condition and overall financial performance.
Significant movements in foreign currency exchange rates have adversely impacted our financial results in the past and may adversely impact our results in the future.
Acquisitions are a significant part of our growth strategy. If we are unable to identify suitable acquisition candidates, complete proposed acquisitions or successfully integrate the businesses we acquire, our growth strategy may not succeed, and we may not realize the anticipated benefits of our acquisitions.
We may require additional capital to finance our acquisitions and operation needs, and such capital may not be available, impacting our ability to pursue our growth strategy.
Our restructuring activities may subject us to additional uncertainty in our operating results.
Any impairment in the value of our intangible assets, including Goodwill, would negatively affect our operating results and total capitalization.
Our electronic information systems have been, and could in the future be, subject to service interruptions, data corruption, cyber-based attacks, network security breaches and other cybersecurity incidents. Significant disruptions in, or breaches in security of, our electronic information systems or data can adversely affect our business and financial statements.
The other 26 risks
Our existing and any future indebtedness could adversely affect our businesses and our ability to meet our obligations and pay dividends.
We may be unable to generate sufficient cash to service all of our indebtedness and may be forced to take other actions to satisfy our obligations under our indebtedness, which may not be successful.
A material disruption at any of our manufacturing facilities could adversely affect our ability to generate sales and meet customer demand.
Failure to maintain and protect our intellectual property rights or challenges to these rights by third parties may affect our operations and financial performance.
We are dependent on the availability of raw materials, as well as parts and components used in our products.
The markets we serve are highly competitive. If we are unable to respond successfully to this competition, this could reduce our sales and operating margins.
Changes in our tax rates or exposure to additional income tax liabilities could adversely affect our financial results.
Our business subjects us to the possibility of product liability lawsuits, which could harm our business.
If our associates represented by trade unions or works councils engage in a strike, work stoppage or other slowdown or if the representation committees responsible for negotiating with such trade unions or works councils are unsuccessful in negotiating new and acceptable agreements when the existing agreements with associates covered by collective bargaining expire, we could experience business disruptions or increased costs.
Our defined benefit pension plans and post-retirement medical and death benefit plans are or may become subject to funding requirements or obligations that could adversely affect our business, financial condition and results of operations.
Our hedging activity could negatively impact our results of operations, cash flows, or leverage.
The loss of key leadership could have a material adverse effect on our ability to run our business.
Failure to successfully integrate new technologies, including artificial intelligence and machine learning, could limit our ability to grow and maintain our competitive position and adversely affect our financial condition, results of operations and cash flow.
Risks Related to Litigation and Regulatory Compliance
Available insurance coverage, the number of future asbestos-related claims and the average settlement value of current and future asbestos-related claims of certain subsidiaries could be different than current estimates, which could materially and adversely affect our business, financial condition and results of operations.
We have done and may continue to do business in countries subject to United States sanctions. Failure to comply with various sanction laws may result in enforcement or other regulatory actions.
If we fail to comply with export control regulations, we could be subject to substantial fines or other sanctions, which could have a material adverse effect on our business, financial condition and results of operations.
We are subject to a variety of continuously evolving and developing laws and regulations regarding privacy, data protection and data security.
We are subject to a variety of increasingly stringent environmental and health and safety laws for which compliance, or related liabilities, could be costly.
We are exposed to certain regulatory and financial risks related to climate change, which could adversely affect our business, financial condition, results of operations and cash flows.
Our businesses are subject to extensive regulation; failure to comply with those regulations could adversely affect our reputation and our business, financial condition and results of operations.
Risks Related to Shares of Our Common Stock
If we are unable to maintain effective internal control over financial reporting in the future, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock may be negatively affected.
Our stock price may fluctuate significantly, including from future sales of our common stock or the perception that such sales or resales may occur.
We cannot guarantee the payment of dividends on our common stock, or the timing or amount of any such dividends.
Issuance of our equity securities may significantly dilute our existing stockholders.
Certain provisions in our certificate of incorporation and amended and restated bylaws (our “bylaws”), and of Delaware law, may prevent or delay an acquisition of us, which could decrease the trading price of our common stock.
Our certificate of incorporation designates the exclusive forum for the resolution of certain types of actions and proceedings that may be initiated by our stockholders. These forum selection provisions could discourage lawsuits against us and our directors, officers, employees and stockholders.
Legal proceedings
Discussion of legal matters is incorporated by reference to Part II, Item 8. Note 19, “Commitments and Contingencies,” in the Notes to Consolidated Financial Statements.
